Matthias Saar

Jun 29, 2023 | mdpi.com | Fidelis Andrea Flockerzi |Johannes Hohneck |Matthias Saar |Rainer Bohle

Abstract:Prostate cancer is one of the most common malignancies worldwide, showing a wide range of clinical behaviors. Therefore, several treatment options arise out of the diagnosis “prostate cancer”. For this reason, it is desirable to find novel prognostic and predictive markers. In former studies, we showed that THSD7A expression is associated with unfavorable prognostic parameters in prostate cancer and is linked to a high expression of focal adhesion kinase (FAK).